Genmab — Marts 2023
-
March 29, 2023 : Annual General Meeting 2023 https://www.proinvestor.com/investornyt/960870/march-29-2023-annual-general-meeting-2023
-
Bank of America Securities analyst Sachin Jain maintained a Buy rating on Genmab (GMAB – Research Report) yesterday and set a price target of $48.00. https://markets.businessinsider.com/news/stocks/bank-of-america-securities-reaffirms-their-buy-rating-on-genmab-gmab-1032196485
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
or it's my clumsy fingers. 3,300 yes